[go: up one dir, main page]

WO2016107110A1 - Hydroxyapatite nerve scaffold and manufacturing method therefor - Google Patents

Hydroxyapatite nerve scaffold and manufacturing method therefor Download PDF

Info

Publication number
WO2016107110A1
WO2016107110A1 PCT/CN2015/082175 CN2015082175W WO2016107110A1 WO 2016107110 A1 WO2016107110 A1 WO 2016107110A1 CN 2015082175 W CN2015082175 W CN 2015082175W WO 2016107110 A1 WO2016107110 A1 WO 2016107110A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxyapatite
nerve
stent
film
scaffold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2015/082175
Other languages
French (fr)
Chinese (zh)
Inventor
李扬德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DONGGUAN DIANFU PRODUCT DESIGN Co Ltd
Original Assignee
DONGGUAN DIANFU PRODUCT DESIGN Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DONGGUAN DIANFU PRODUCT DESIGN Co Ltd filed Critical DONGGUAN DIANFU PRODUCT DESIGN Co Ltd
Publication of WO2016107110A1 publication Critical patent/WO2016107110A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Definitions

  • the invention relates to the technical field of nerve stents, in particular to a hydroxyapatite nerve stent and a preparation method thereof.
  • Peripheral nerve damage or breakage due to various trauma causes a decrease or loss of sensory and motor function. Severe peripheral nerve injury often leads to paralysis or permanent loss of labor. Peripheral nerve injury has a high incidence in China. According to statistics, in trauma patients, nerve injury of the extremities accounts for about 10% of the total number of trauma, and about 60% of the fractures of firearm injuries have neurological injuries. To this end, we need to find the ideal treatment for peripheral nerve injury. For peripheral nerve fractures, if the fracture gap is large, the fractured peripheral nerve must be regenerated and repaired by bridging the graft.
  • Hydroxyapatite is the main inorganic component of human and animal bones and teeth. Its physical and chemical composition is very similar to the inorganic composition of human bone. It has good biocompatibility, bioactivity and osteoconductivity, and human bone tissue. Excellent chemical and biological affinity. Bioactive ceramics prepared from hydroxyapatite are not only safe, non-toxic, but also capable of conducting bone growth. However, the use of hydroxyapatite for the preparation of nerve scaffolds for nerve repair has not been reported so far.
  • the present invention provides a hydroxyapatite nerve scaffold and a preparation method thereof.
  • the neural scaffold prepared by the method has good mechanical properties, is biodegradable, and has a three-dimensional structure required for nerve regeneration. Repair has far-reaching significance.
  • a hydroxyapatite nerve stent comprising a stent film and a degradable metal wire wrapped by a stent film, and the main component of the stent film is hydroxyapatite.
  • the stent is in the form of a sheet, a strip or a cylinder.
  • the degradable wires are distributed along the lateral and longitudinal directions of the stent.
  • the main component of the degradable metal wire is magnesium, zinc, calcium, iron or an alloy thereof.
  • the preparation method of the hydroxyapatite nerve stent comprises the following steps:
  • hydroxyapatite powder was taken, calcined at 900 ° C for 3 hours, cooled and dissolved in distilled water, and ultrasonically shaken for 30 min to make it uniformly dispersed to obtain a hydroxyapatite slurry.
  • the mass concentration is 10-50%;
  • the nerve scaffold has a porosity of 40-65%.
  • the hydroxyapatite nerve scaffold of the invention has good mechanical properties, biodegradability, and has the three-dimensional structure required for nerve regeneration, and has profound significance for nerve repair.
  • FIG. 1 is a schematic view showing the structure of a hydroxyapatite nerve stent according to the present invention.
  • Figures 2a, 2b and 2c are photographs of the upper surface, lower surface and longitudinal surface of the resulting hydroxyapatite nerve stent observed under a microscope.
  • a hydroxyapatite nerve stent comprises a stent film 1 and a degradable metal wire 2 wrapped by a stent film 1.
  • the degradable wires are distributed along the lateral and longitudinal directions of the stent.
  • the stent can be prepared into various shapes according to the needs of use, and is generally cylindrical or sheet-shaped.
  • the nerve scaffold has a porosity of 40-65%.
  • the stent film 1 is hydroxyapatite.
  • the main component of the degradable metal wire 2 is magnesium, zinc, calcium, iron or an alloy thereof.
  • Embodiment 1 a method for preparing a hydroxyapatite nerve stent, comprising the following steps:
  • hydroxyapatite powder was taken, calcined at 900 ° C for 3 hours, cooled and dissolved in distilled water, and ultrasonically shaken for 30 min to make it uniformly dispersed to obtain a hydroxyapatite slurry.
  • the mass concentration is 40%;
  • Figures 2a, 2b and 2c are photographs of the upper surface, lower surface and longitudinal surface of the artificial nerve stent obtained under a microscope.
  • Embodiment 2 a method for preparing a hydroxyapatite nerve stent, comprising the following steps:
  • hydroxyapatite powder is taken, calcined at 800-° C. for 3 hours, cooled, dissolved in distilled water, and shaken by ultrasonic for 40 min to uniformly disperse to obtain a hydroxyapatite slurry. Its mass concentration is 50%;

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

A hydroxyapatite nerve scaffold comprising a scaffold membrane (1) and a degradable metal wire (2) wrapped by the scaffold membrane (1). The primary constituent of the scaffold membrane (1) is hydroxyapatite. The artificial nerve scaffold manufactured per the method has great mechanical properties, is biodegradable, provides a three-dimensional structure required for neuroregeneration, and has profound significance in neurorestoration.

Description

一种羟基磷灰石神经支架及其制备方法Hydroxyapatite nerve scaffold and preparation method thereof 技术领域Technical field

本发明涉及神经支架技术领域,具体地,涉及一种羟基磷灰石神经支架及其制备方法。The invention relates to the technical field of nerve stents, in particular to a hydroxyapatite nerve stent and a preparation method thereof.

背景技术Background technique

由于各种外伤原因导致的周围神经损伤或断裂造成伤者感觉和运动功能的下降或丧失。严重的外周神经损伤往往导致患者瘫痪或永久丧失劳动力。外周神经损伤在我国发病率较高,据统计,在外伤患者中,四肢神经伤约占外伤总数的10%,火器伤骨折中约有60%的合并神经伤。为此,需寻找理想的外周神经伤治疗手段。对于外周神经断裂类损伤,若断裂缺口较大,就须借助对缺口进行桥接移植手术才能使断裂的周围神经得到再生修复。Peripheral nerve damage or breakage due to various trauma causes a decrease or loss of sensory and motor function. Severe peripheral nerve injury often leads to paralysis or permanent loss of labor. Peripheral nerve injury has a high incidence in China. According to statistics, in trauma patients, nerve injury of the extremities accounts for about 10% of the total number of trauma, and about 60% of the fractures of firearm injuries have neurological injuries. To this end, we need to find the ideal treatment for peripheral nerve injury. For peripheral nerve fractures, if the fracture gap is large, the fractured peripheral nerve must be regenerated and repaired by bridging the graft.

目前,常用的移植体有自体移植体和人工神经支架。自体移植体来源有限且会带来供体后遗症。人工神经支架方面,由于非降解导管材料可能导致神经压迫和二次手术的风险,近年来研究的主要趋向于生物可降解支架材料的开发和研究。当前,美国已经批准多种品牌,如,NeuraGen、SaluBridge,Neurolac等的神经导管用于临床。然而,我国在神经支架方面的研究较为落后,并没有开发出具有自主知识产权的神经导管。Currently, commonly used implants include autografts and artificial nerve stents. Autologous grafts have limited sources and can cause donor sequelae. In terms of artificial nerve stents, the development of non-degradable catheter materials may lead to nerve compression and the risk of secondary surgery. In recent years, research has mainly led to the development and research of biodegradable stent materials. Currently, the United States has approved a variety of brands, such as NeuraGen, SaluBridge, Neurolac and other nerve catheters for clinical use. However, China's research on nerve scaffolds is relatively backward, and no neural catheters with independent intellectual property rights have been developed.

羟基磷灰石是人体和动物体骨骼、牙齿的主要无机成分,其物理化学组成与人体骨的无机组成极为相似,具有良好的生物相容性、生物活性和骨传导性,而且和人体骨组织具有极好的化学和生物亲和性。羟基磷灰石制备的生物活性陶瓷置入体内不仅安全、无毒,还能传导骨生长。然而,将羟基磷灰石用于制备神经支架用于神经修复,目前还未见报道。Hydroxyapatite is the main inorganic component of human and animal bones and teeth. Its physical and chemical composition is very similar to the inorganic composition of human bone. It has good biocompatibility, bioactivity and osteoconductivity, and human bone tissue. Excellent chemical and biological affinity. Bioactive ceramics prepared from hydroxyapatite are not only safe, non-toxic, but also capable of conducting bone growth. However, the use of hydroxyapatite for the preparation of nerve scaffolds for nerve repair has not been reported so far.

发明内容Summary of the invention

为了克服现有技术的不足,本发明提供了一种羟基磷灰石神经支架及其制备方法,该方法制备的神经支架力学性能良好,生物可降解,具有神经再生所需要的三维结构,对神经修复具有深远的意义。In order to overcome the deficiencies of the prior art, the present invention provides a hydroxyapatite nerve scaffold and a preparation method thereof. The neural scaffold prepared by the method has good mechanical properties, is biodegradable, and has a three-dimensional structure required for nerve regeneration. Repair has far-reaching significance.

本发明的技术方案如下:一种羟基磷灰石神经支架,包括支架膜料以及支架膜料包裹的可降解金属丝,所述支架膜料的主要成分为羟基磷灰石。The technical scheme of the present invention is as follows: a hydroxyapatite nerve stent comprising a stent film and a degradable metal wire wrapped by a stent film, and the main component of the stent film is hydroxyapatite.

所述支架为片状,长条状或圆柱状。The stent is in the form of a sheet, a strip or a cylinder.

所述可降解金属丝沿所述支架的横向和纵向分布。The degradable wires are distributed along the lateral and longitudinal directions of the stent.

所述可降解金属丝的主要成分为镁,锌,钙,铁或其合金。The main component of the degradable metal wire is magnesium, zinc, calcium, iron or an alloy thereof.

所述羟基磷灰石神经支架的制备方法,包括如下步骤:The preparation method of the hydroxyapatite nerve stent comprises the following steps:

1)制备粘结剂:称量3g羧甲基纤维素溶解于60ml蒸馏水中,用控温磁力搅拌器加热至40℃并搅拌30min至溶液澄清,得到羧甲基纤维素溶液;1) Preparation of binder: Weigh 3g of carboxymethyl cellulose dissolved in 60ml of distilled water, heated to 40 ° C with a temperature-controlled magnetic stirrer and stirred for 30min until the solution is clarified to obtain a carboxymethyl cellulose solution;

2)制备羟基磷灰石浆料:取羟基磷灰石粉末,在900℃煅烧3小时,冷却后溶解于蒸馏水中,用超声波振荡30min,使其分散均匀,得到羟基磷灰石浆料,其质量浓度为10-50%;2) Preparation of hydroxyapatite slurry: hydroxyapatite powder was taken, calcined at 900 ° C for 3 hours, cooled and dissolved in distilled water, and ultrasonically shaken for 30 min to make it uniformly dispersed to obtain a hydroxyapatite slurry. The mass concentration is 10-50%;

3)制备支架膜料:在步骤2)所得羟基磷灰石浆料中加入1-1.5%体积的步骤1所得羧甲基纤维素溶液,用磁力搅拌器搅拌1h,真空箱中静置24h,脱去浆料中的气体,得到所述支架膜料;3) Preparation of the stent film: 1-1.5% by volume of the carboxymethyl cellulose solution obtained in the step 1 was added to the hydroxyapatite slurry obtained in the step 2), stirred for 1 hour with a magnetic stirrer, and allowed to stand in a vacuum box for 24 hours. Removing the gas in the slurry to obtain the stent film material;

4)将所述支架膜料注入特制模具的模腔中,模腔中沿支架膜料成型方向的横向和纵向设置可降解金属丝,在-10--70℃冷冻,而后将模具取出放入抽虑设备,并接上真空泵,置于冰柜中进行抽真空干燥;而后,在200-400℃高温排胶,除去甲基纤维素,再在1000-1200烧结2-6小时,得到所述羟基磷灰石神经支架。4) injecting the stent film into a cavity of a special mold, and disposing a degradable wire in a lateral direction and a longitudinal direction in a molding direction of the stent film, freezing at -10-70 ° C, and then taking out the mold The equipment is pumped up, connected to a vacuum pump, placed in a freezer for vacuum drying; then, at a high temperature of 200-400 ° C, the methyl cellulose is removed, and then sintered at 1000-1200 for 2-6 hours to obtain the hydroxyl group. Apatite nerve support.

所述神经支架的孔隙率为40-65%。 The nerve scaffold has a porosity of 40-65%.

本发明的有益效果为:本发明所述羟基磷灰石神经支架力学性能良好,生物可降解,具有神经再生所需要的三维结构,对神经修复具有深远的意义。The beneficial effects of the invention are as follows: the hydroxyapatite nerve scaffold of the invention has good mechanical properties, biodegradability, and has the three-dimensional structure required for nerve regeneration, and has profound significance for nerve repair.

附图说明:BRIEF DESCRIPTION OF THE DRAWINGS:

图1为本发明所述羟基磷灰石神经支架的结构示意图。1 is a schematic view showing the structure of a hydroxyapatite nerve stent according to the present invention.

图2a,2b和2c为用显微镜下观测所得羟基磷灰石神经支架的上表面,下表面和纵向表面照片。Figures 2a, 2b and 2c are photographs of the upper surface, lower surface and longitudinal surface of the resulting hydroxyapatite nerve stent observed under a microscope.

具体实施方式detailed description

下面结合附图和优选实施例对本发明作进一步的描述,但本发明的实施方式不限于此。The present invention will be further described below in conjunction with the drawings and preferred embodiments, but the embodiments of the present invention are not limited thereto.

参照图1,一种羟基磷灰石神经支架,包括支架膜料1以及支架膜料1包裹的可降解金属丝2。所述可降解金属丝沿所述支架的横向和纵向分布。所述支架可以根据使用需要制备成各种形状,一般为圆筒形,也可以是片状。所述神经支架的孔隙率为40-65%。Referring to Fig. 1, a hydroxyapatite nerve stent comprises a stent film 1 and a degradable metal wire 2 wrapped by a stent film 1. The degradable wires are distributed along the lateral and longitudinal directions of the stent. The stent can be prepared into various shapes according to the needs of use, and is generally cylindrical or sheet-shaped. The nerve scaffold has a porosity of 40-65%.

所述支架膜料1为羟基磷灰石。所述可降解金属丝2的主要成分为镁,锌,钙,铁或其合金。The stent film 1 is hydroxyapatite. The main component of the degradable metal wire 2 is magnesium, zinc, calcium, iron or an alloy thereof.

实施例1,一种羟基磷灰石神经支架的制备方法,包括如下步骤:Embodiment 1, a method for preparing a hydroxyapatite nerve stent, comprising the following steps:

1)制备粘结剂:称量羧甲基纤维素溶解于蒸馏水中,用控温磁力搅拌器加热至40℃并搅拌30min至溶液澄清,得到羧甲基纤维素溶液,其质量浓度为5%;1) Preparation of binder: Weigh carboxymethyl cellulose dissolved in distilled water, heated to 40 ° C with a temperature-controlled magnetic stirrer and stirred for 30 min until the solution is clarified to obtain a carboxymethyl cellulose solution with a mass concentration of 5%. ;

2)制备羟基磷灰石浆料:取羟基磷灰石粉末,在900℃煅烧3小时,冷却后溶解于蒸馏水中,用超声波振荡30min,使其分散均匀,得到羟基磷灰石浆料,其质量浓度为40%; 2) Preparation of hydroxyapatite slurry: hydroxyapatite powder was taken, calcined at 900 ° C for 3 hours, cooled and dissolved in distilled water, and ultrasonically shaken for 30 min to make it uniformly dispersed to obtain a hydroxyapatite slurry. The mass concentration is 40%;

3)制备支架膜料:在步骤2)所得羟基磷灰石浆料中加入1.5%体积的步骤1所得羧甲基纤维素溶液,用磁力搅拌器搅拌1h,真空箱中静置24h,脱去浆料中的气体,得到所述支架膜料;3) Preparation of the stent film: 1.5% by volume of the carboxymethyl cellulose solution obtained in the step 1 was added to the hydroxyapatite slurry obtained in the step 2), stirred for 1 hour with a magnetic stirrer, and allowed to stand in a vacuum box for 24 hours. a gas in the slurry to obtain the scaffold film;

4)将所述支架膜料注入特制模具的模腔中,模腔中沿支架膜料成型方向的横向和纵向设置可降解金属丝,在-10℃冷冻,而后将模具取出放入抽虑设备,并接上真空泵,置于冰柜中进行抽真空干燥;而后,在200-400℃高温排胶,除去甲基纤维素,再在1050烧结2-6小时,得到所述羟基磷灰石神经支架。4) injecting the stent film into a cavity of a special mold, disposing a degradable wire in a lateral direction and a longitudinal direction in a molding direction of the stent film, freezing at -10 ° C, and then taking out the mold into a pumping device And connected to a vacuum pump, placed in a freezer for vacuum drying; then, at 200-400 ° C high temperature, remove methyl cellulose, and then sintered at 1050 for 2-6 hours to obtain the hydroxyapatite nerve stent .

图2a,2b和2c为用显微镜下观测所得人工神经支架的上表面,下表面和纵向表面照片。Figures 2a, 2b and 2c are photographs of the upper surface, lower surface and longitudinal surface of the artificial nerve stent obtained under a microscope.

实施例2,一种羟基磷灰石神经支架的制备方法,包括如下步骤:Embodiment 2, a method for preparing a hydroxyapatite nerve stent, comprising the following steps:

1)制备粘结剂:称量羧甲基纤维素溶解于蒸馏水中,用控温磁力搅拌器加热至40℃并搅拌30min至溶液澄清,得到羧甲基纤维素溶液,其质量浓度为3%;1) Preparation of binder: Weigh carboxymethyl cellulose dissolved in distilled water, heated to 40 ° C with a temperature-controlled magnetic stirrer and stirred for 30 min until the solution is clarified to obtain a carboxymethyl cellulose solution with a mass concentration of 3%. ;

2)制备羟基磷灰石浆料:取羟基磷灰石粉末,在800-℃煅烧3小时,冷却后溶解于蒸馏水中,用超声波振荡40min,使其分散均匀,得到羟基磷灰石浆料,其质量浓度为50%;2) Preparation of hydroxyapatite slurry: hydroxyapatite powder is taken, calcined at 800-° C. for 3 hours, cooled, dissolved in distilled water, and shaken by ultrasonic for 40 min to uniformly disperse to obtain a hydroxyapatite slurry. Its mass concentration is 50%;

3)制备支架膜料:在步骤2)所得羟基磷灰石浆料中加入1%体积的步骤1所得羧甲基纤维素溶液,用磁力搅拌器搅拌1h,真空箱中静置24h,脱去浆料中的气体,得到所述支架膜料;3) Preparation of the stent film: 1% by volume of the carboxymethyl cellulose solution obtained in the step 1 was added to the hydroxyapatite slurry obtained in the step 2), stirred for 1 hour with a magnetic stirrer, and allowed to stand in a vacuum box for 24 hours. a gas in the slurry to obtain the scaffold film;

4)将所述支架膜料注入特制模具的模腔中,模腔中沿支架膜料成型方向的横向和纵向设置可降解金属丝,在-70℃冷冻,而后将模具取出放入抽虑设备,并接上真空泵,置于冰柜中进行抽真空干燥;而后,在200-400℃高温排胶,除去甲基纤维素,再在1000-1200烧结2-6小时,得到所述羟基磷灰石神经支架。 4) injecting the stent film into a cavity of a special mold, disposing a degradable wire in a lateral direction and a longitudinal direction in a molding direction of the stent film, freezing at -70 ° C, and then taking out the mold into a pumping device And connected to a vacuum pump, placed in a freezer for vacuum drying; then, at 200-400 ° C high temperature, remove methyl cellulose, and then sintered at 1000-1200 for 2-6 hours to obtain the hydroxyapatite Nerve stent.

以上内容是结合具体的优选实施方式对本发明所作的进一步详细说明,不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的前提下,其架构形式能够灵活多变,可以派生系列产品。只是做出若干简单推演或替换,都应当视为属于本发明由所提交的权利要求书确定的专利保护范围。 The above is a further detailed description of the present invention in connection with the specific preferred embodiments, and the specific embodiments of the present invention are not limited to the description. For those skilled in the art to which the present invention pertains, the architectural form can be flexible and can be derived from a series of products without departing from the inventive concept. It is to be understood that the invention is intended to be limited to the scope of the invention as defined by the appended claims.

Claims (6)

一种羟基磷灰石神经支架,其特征在于,包括支架膜料以及支架膜料包裹的可降解金属丝,所述支架膜料的主要成分为羟基磷灰石。A hydroxyapatite nerve scaffold characterized by comprising a scaffold film and a degradable metal wire wrapped by a scaffold film, the main component of the scaffold film being hydroxyapatite. 如权利要求1所述的羟基磷灰石神经支架,其特征在于,所述支架为片状,长条状或圆柱状。The hydroxyapatite nerve stent according to claim 1, wherein the stent is in the form of a sheet, an elongated strip or a cylinder. 如权利要求1所述的羟基磷灰石神经支架,其特征在于,所述可降解金属丝沿所述支架的横向和纵向分布。The hydroxyapatite nerve stent according to claim 1, wherein the degradable metal wire is distributed along a lateral direction and a longitudinal direction of the stent. 如权利要求1所述的羟基磷灰石神经支架,其特征在于,所述可降解金属丝的主要成分为镁,锌,钙,铁或其合金。The hydroxyapatite nerve stent according to claim 1, wherein the main component of the degradable metal wire is magnesium, zinc, calcium, iron or an alloy thereof. 如权利要求1-4任一项所述羟基磷灰石神经支架的制备方法,其特征在于,包括如下步骤:The method for preparing a hydroxyapatite nerve stent according to any one of claims 1 to 4, comprising the steps of: 1)制备粘结剂:称量3g羧甲基纤维素溶解于60ml蒸馏水中,用控温磁力搅拌器加热至40℃并搅拌30min至溶液澄清,得到羧甲基纤维素溶液;1) Preparation of binder: Weigh 3g of carboxymethyl cellulose dissolved in 60ml of distilled water, heated to 40 ° C with a temperature-controlled magnetic stirrer and stirred for 30min until the solution is clarified to obtain a carboxymethyl cellulose solution; 2)制备羟基磷灰石浆料:取羟基磷灰石粉末,在900℃煅烧3小时,冷却后溶解于蒸馏水中,用超声波振荡30min,使其分散均匀,得到羟基磷灰石浆料,其质量浓度为10-50%;2) Preparation of hydroxyapatite slurry: hydroxyapatite powder was taken, calcined at 900 ° C for 3 hours, cooled and dissolved in distilled water, and ultrasonically shaken for 30 min to make it uniformly dispersed to obtain a hydroxyapatite slurry. The mass concentration is 10-50%; 3)制备支架膜料:在步骤2)所得羟基磷灰石浆料中加入1-1.5%体积的步骤1所得羧甲基纤维素溶液,用磁力搅拌器搅拌1h,真空箱中静置24h,脱去浆料中的气体,得到所述支架膜料;3) Preparation of the stent film: 1-1.5% by volume of the carboxymethyl cellulose solution obtained in the step 1 was added to the hydroxyapatite slurry obtained in the step 2), stirred for 1 hour with a magnetic stirrer, and allowed to stand in a vacuum box for 24 hours. Removing the gas in the slurry to obtain the stent film material; 4)将所述支架膜料注入特制模具的模腔中,模腔中沿支架膜料成型方向的横向和纵向设置可降解金属丝,在-10--70℃冷冻,而后将模具取出放入抽虑设备,并接上真空泵,置于冰柜中进行抽真空干燥;而后,在200-400℃高温排胶,除去甲基纤维素,再在1000-1200烧结2-6小时,得到所述羟基磷灰石神经支架。 4) injecting the stent film into a cavity of a special mold, and disposing a degradable wire in a lateral direction and a longitudinal direction in a molding direction of the stent film, freezing at -10-70 ° C, and then taking out the mold The equipment is pumped up, connected to a vacuum pump, placed in a freezer for vacuum drying; then, at a high temperature of 200-400 ° C, the methyl cellulose is removed, and then sintered at 1000-1200 for 2-6 hours to obtain the hydroxyl group. Apatite nerve support. 如权利要求5所述的羟基磷灰石神经支架的制备方法,其特征在于,所述神经支架的孔隙率为40-65%。 The method for preparing a hydroxyapatite nerve stent according to claim 5, wherein the nerve stent has a porosity of 40-65%.
PCT/CN2015/082175 2014-12-29 2015-06-24 Hydroxyapatite nerve scaffold and manufacturing method therefor Ceased WO2016107110A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410834302.9A CN104524628B (en) 2014-12-29 2014-12-29 A kind of hydroxyapatite Nerve Scaffold and preparation method thereof
CN201410834302.9 2014-12-29

Publications (1)

Publication Number Publication Date
WO2016107110A1 true WO2016107110A1 (en) 2016-07-07

Family

ID=52840374

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/082175 Ceased WO2016107110A1 (en) 2014-12-29 2015-06-24 Hydroxyapatite nerve scaffold and manufacturing method therefor

Country Status (2)

Country Link
CN (1) CN104524628B (en)
WO (1) WO2016107110A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204394742U (en) * 2014-12-29 2015-06-17 东莞颠覆产品设计有限公司 A kind of real core Nerve Scaffold of built-in degradable metal silk
CN104524628B (en) * 2014-12-29 2016-11-02 东莞颠覆产品设计有限公司 A kind of hydroxyapatite Nerve Scaffold and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562383A (en) * 2004-03-16 2005-01-12 武汉理工大学 Aretificial nerve canula material of slow operating complex type poly lactic acid and preparation method
US20100047310A1 (en) * 2008-08-21 2010-02-25 Taipei Medical University Bio-acceptable conduits and method providing the same
CN102000362A (en) * 2010-12-02 2011-04-06 上海纳米技术及应用国家工程研究中心有限公司 Silk fibroin/nano hydroxyapatite porous bracket material and preparation method thereof
CN102149859A (en) * 2009-06-25 2011-08-10 三维生物科技有限公司 Methods and apparatus for fabricating porous three-dimensional tubular scaffolds
CN104107096A (en) * 2014-07-18 2014-10-22 上海交通大学 Bendable fully-degrading magnesium alloy nerve conduit and preparing method thereof
CN104524628A (en) * 2014-12-29 2015-04-22 东莞颠覆产品设计有限公司 Hydroxyapatite nerve scaffold and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562383A (en) * 2004-03-16 2005-01-12 武汉理工大学 Aretificial nerve canula material of slow operating complex type poly lactic acid and preparation method
US20100047310A1 (en) * 2008-08-21 2010-02-25 Taipei Medical University Bio-acceptable conduits and method providing the same
CN102149859A (en) * 2009-06-25 2011-08-10 三维生物科技有限公司 Methods and apparatus for fabricating porous three-dimensional tubular scaffolds
CN102000362A (en) * 2010-12-02 2011-04-06 上海纳米技术及应用国家工程研究中心有限公司 Silk fibroin/nano hydroxyapatite porous bracket material and preparation method thereof
CN104107096A (en) * 2014-07-18 2014-10-22 上海交通大学 Bendable fully-degrading magnesium alloy nerve conduit and preparing method thereof
CN104524628A (en) * 2014-12-29 2015-04-22 东莞颠覆产品设计有限公司 Hydroxyapatite nerve scaffold and preparation method thereof

Also Published As

Publication number Publication date
CN104524628A (en) 2015-04-22
CN104524628B (en) 2016-11-02

Similar Documents

Publication Publication Date Title
CN101474430B (en) Tissue regeneration membrane with bioactivity and preparation method thereof
WO2016107109A1 (en) Collagen-hydroxyapatite nerve scaffold and manufacturing method therefor
CN104353110B (en) For the bone holder material with shape memory function and preparation method thereof of jawbone reparation
JP2022088628A (en) Bone transplant substitute
CN101987208A (en) Multi-phase large-aperture bone regeneration bracket material transformed from cuttlebone and preparation method thereof
WO2017118293A1 (en) Degradable bone implant, and manufacturing method thereof
Vyas et al. Sustainable sources of raw materials as substituting biomaterials for additive manufacturing of dental implants: a review
CN104761253A (en) A functional biomimetic composite biological piezoelectric ceramic material and a preparing method thereof
EP3241524A1 (en) Solid-core nerve scaffold having built-in degradable metal wire
KR20150006507A (en) Method for producing porous bone substitute and injector for bone substitute
CN111773432A (en) Magnesium-based amorphous-calcium phosphate/calcium silicate composite filler and its preparation and application
CN116392638B (en) 3D printing construction and preparation method of vancomycin-loaded hierarchical pore artificial bone scaffold model
WO2016107110A1 (en) Hydroxyapatite nerve scaffold and manufacturing method therefor
WO2011130812A2 (en) Suspensions for preparing biosilicate-based bone grafts (scaffolds), thus obtained bone grafts and methods for producing same
WO2016107112A1 (en) Collagen-rich artificial nerve scaffold and manufacturing method therefor
WO2016107107A1 (en) Animal-derived nerve scaffold and manufacturing method therefor
RU2554804C1 (en) Method for preparing calcium phosphate composite
CN102764454A (en) Degradable absorptive poly lactic-co-glycolic acid (PLGA)-Mg series composite medical implant and preparation method thereof
CN107899088B (en) A porous bioscaffold for preventing fracture after removal of internal fixator and preparation thereof
WO2016107108A1 (en) Polylactic acid nerve scaffold and manufacturing method therefor
CN105031727A (en) Drug loaded composite bone restoration material and preparation method thereof
CN109316627A (en) A new type of artificial bone material and its preparation method and application
CN111773434A (en) Magnesium strontium-calcium phosphate/calcium silicate composite bone cement filler and its preparation and application
Bag Biodegradable composite scaffold for bone tissue regeneration
CN104623742A (en) Bioactive absorbable medical strapping tape and forming method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15874800

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 16/11/2017)

122 Ep: pct application non-entry in european phase

Ref document number: 15874800

Country of ref document: EP

Kind code of ref document: A1